Looks like Kolon life science who is developing Invossa got a smack on the hand for misleading information about there product, and whats in it and the source of it.I wouldn't imagine this would sit very well with the FDA especially if it was intentional.
If interested search(Kolon CEO arrested for mislabelling Invossa's ingredient).
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-2867
-
- There are more pages in this discussion • 1,562 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $70.04M |
Open | High | Low | Value | Volume |
21.0¢ | 21.0¢ | 20.0¢ | $201.6K | 994.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 429247 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 13806 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 389247 | 0.200 |
8 | 133607 | 0.195 |
17 | 238789 | 0.190 |
4 | 92160 | 0.185 |
8 | 122773 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 13806 | 2 |
0.215 | 28509 | 1 |
0.220 | 59615 | 6 |
0.225 | 28604 | 2 |
0.230 | 16334 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |